These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 17470328)
1. The US Food and Drug Administration: a dysfunctional agency in need of major reforms. Nissen SE Curr Cardiol Rep; 2007 May; 9(3):167-9. PubMed ID: 17470328 [No Abstract] [Full Text] [Related]
2. The FDA Drug Safety Bill: how safe are our drugs? Cobert B Expert Opin Drug Saf; 2008 Jul; 7(4):343-6. PubMed ID: 18613798 [TBL] [Abstract][Full Text] [Related]
3. Generally Regarded As Safe. Novack GD Ocul Surf; 2017 Jan; 15(1):152-155. PubMed ID: 27871773 [No Abstract] [Full Text] [Related]
4. The QAU: friend, not foe. Sewell AF; Spencer CD J Clin Pharmacol; 1991 Jun; 31(6):509-11. PubMed ID: 1880214 [No Abstract] [Full Text] [Related]
5. US lawmakers tackle safety reforms at the FDA. Zwillich T Lancet; 2007 Jun; 369(9578):1989-90. PubMed ID: 17577942 [No Abstract] [Full Text] [Related]
6. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission. Joffe S; Lynch HF N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302 [No Abstract] [Full Text] [Related]
7. Assessing Drug Safety in Children - The Role of Real-World Data. McMahon AW; Dal Pan G N Engl J Med; 2018 Jun; 378(23):2155-2157. PubMed ID: 29874532 [No Abstract] [Full Text] [Related]
8. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health. Gostin LO JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642 [No Abstract] [Full Text] [Related]
9. Pharmaceutical and Medical Devices: FDA Oversight. White RS; Issue Brief Health Policy Track Serv; 2015 Dec; ():1-97. PubMed ID: 27116797 [No Abstract] [Full Text] [Related]
10. Today's requirements in food, drug and chemical control. Osterberg RE Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():201-28. PubMed ID: 6880782 [No Abstract] [Full Text] [Related]
11. The medical-legal aspects of adverse drug reactions. Tozer FL; Kasik JE Clin Pharmacol Ther; 1967; 8(5):637-46. PubMed ID: 6072449 [No Abstract] [Full Text] [Related]
13. Discovering adverse drug reactions. Lasagna L JAMA; 1983 Apr 22-29; 249(16):2224-5. PubMed ID: 6339764 [No Abstract] [Full Text] [Related]
14. Addressing Pharmaceutical Injuries: The US Landscape. Bakker C; Honig N Clin Pharmacol Ther; 2018 Mar; 103(3):384-385. PubMed ID: 28850676 [TBL] [Abstract][Full Text] [Related]
15. Realizing the promise of the US Food and Drug Administration Modernization Act. Wolgemuth RL Clin Ther; 1998; 20 Suppl C():C26-31. PubMed ID: 9915087 [TBL] [Abstract][Full Text] [Related]
16. The role of litigation in defining drug risks. Kesselheim AS; Avorn J JAMA; 2007 Jan; 297(3):308-11. PubMed ID: 17227983 [No Abstract] [Full Text] [Related]
17. A prescription for monitoring drugs. Marshall E Science; 1980 Feb; 207(4433):853-5. PubMed ID: 7355265 [No Abstract] [Full Text] [Related]
18. Nutraceuticals. Curry M; Hazard-Daniel A; Daniel HJ Science; 1999 Dec; 286(5446):1854-5. PubMed ID: 10610573 [No Abstract] [Full Text] [Related]
19. What's current in U.S. drug regulation. Halperin JA Drug Inf J; 1978 OCt-Dec; 12(4):197-203. PubMed ID: 10316752 [No Abstract] [Full Text] [Related]
20. US FDA seeks more pharmaceutical industry cash. Zwillich T Lancet; 2007 Feb; 369(9559):357. PubMed ID: 17283497 [No Abstract] [Full Text] [Related] [Next] [New Search]